Skip to main content
SpringerLink
Log in

Plasma Cell Leukemia

  • Chapter
  • First Online:
Neoplastic Diseases of the Blood

  • 2188 Accesses

Abstract

Plasma cell leukemia is a rare subtype of plasma cell dyscrasias with an aggressive clinical course and poor prognosis. Despite significant advancements in therapeutics for multiple myeloma, we continue to have poor outcomes in patients with plasma cell leukemia. In this chapter, the clinical presentation and diagnosis of plasma cell leukemia are reviewed, as well as a summary of current data available on treatment options and potential future treatment directions for this difficult disease entity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Albarracin F, Fonseca R. Plasma cell leukemia. Blood Rev. 2011;25(3):107–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gluzinski A, Reichenstein M. Myeloma und leucaemia lymphatica plasmocellularis. Wien Klin Wochenschr. 1906;121(5):749–57.

    Google Scholar 

  3. Ramsingh G, et al. Primary plasma cell leukemia: a surveillance, epidemiology, and end results database analysis between 1973 and 2004. Cancer. 2009;115(24):5734–9.

    Article  PubMed  Google Scholar 

  4. Ioannou MG, et al. Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses. Pathol Oncol Res. 2009;15(1):25–9.

    Article  PubMed  Google Scholar 

  5. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111(8):3941–67.

    Article  CAS  PubMed  Google Scholar 

  6. van de Donk NW, et al. How I treat plasma cell leukemia. Blood. 2012;120(12):2376–89.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Tiedemann RE, et al. Genetic aberrations and survival in plasma cell leukemia. Leukemia. 2008;22(5):1044–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Jimenez-Zepeda VH, Neme-Yunes Y, Braggio E. Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology? Eur J Haematol. 2011;87(1):20–7.

    Article  PubMed  Google Scholar 

  9. Chang H, et al. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia. Leuk Res. 2009;33(2):259–62.

    Article  CAS  PubMed  Google Scholar 

  10. Rajkumar SV. Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol. 2012;87(1):78–88.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Musto P, et al. Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia. Leukemia. 2014;28(1):222–5.

    Article  CAS  PubMed  Google Scholar 

  12. Royer B, et al. Bortezomib, doxorubicin, cyclophosphamide, dexamethasone induction followed by stem cell transplantation for primary plasma cell leukemia: a prospective phase II study of the Intergroupe Francophone du Myelome. J Clin Oncol. 2016;34(18):2125–32.

    Article  CAS  PubMed  Google Scholar 

  13. D’Arena G, et al. Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. Ann Oncol. 2012;23(6):1499–502.

    Article  PubMed  Google Scholar 

  14. Pagano L, et al. Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol. 2011;22(7):1628–35.

    Article  CAS  PubMed  Google Scholar 

  15. Katodritou E, et al. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: analysis of the Greek myeloma study group. Am J Hematol. 2014;89(2):145–50.

    Article  CAS  PubMed  Google Scholar 

  16. Musto P, et al. Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer. 2007;109(11):2285–90.

    Article  CAS  PubMed  Google Scholar 

  17. McElwain TJ, Powles RL. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet. 1983;2(8354):822–4.

    Article  CAS  PubMed  Google Scholar 

  18. Drake MB, et al. Primary plasma cell leukemia and autologous stem cell transplantation. Haematologica. 2010;95(5):804–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mahindra A, et al. Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia. 2012;26(5):1091–7.

    Article  CAS  PubMed  Google Scholar 

  20. Gonsalves WI, et al. Trends in survival of patients with primary plasma cell leukemia: a population-based analysis. Blood. 2014;124(6):907–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Dimopoulos MA, et al. Primary plasma cell leukaemia. Br J Haematol. 1994;88(4):754–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd, Building C, Room 4004, Atlanta, 30322, GA, USA

    Nisha S. Joseph M.D. & Sagar Lonial M.D.

Authors
  1. Nisha S. Joseph M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sagar Lonial M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sagar Lonial M.D. .

Editor information

Editors and Affiliations

  1. Cancer Research Foundation, Chappaqua, New York, USA

    Peter H. Wiernik

  2. Cancer Research Foundation, Chappaqua, New York, USA

    Janice P. Dutcher

  3. Department of Hematology, Mayo Clinic Department of Hematology, Rochester, Minnesota, USA

    Morie A. Gertz

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Joseph, N.S., Lonial, S. (2018). Plasma Cell Leukemia. In: Wiernik, P., Dutcher, J., Gertz, M. (eds) Neoplastic Diseases of the Blood. Springer, Cham. https://doi.org/10.1007/978-3-319-64263-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64263-5_34

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64262-8

  • Online ISBN: 978-3-319-64263-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation